| First Author | Dinevska M | Year | 2023 |
| Journal | Brain Behav Immun | Volume | 116 |
| Pages | 140-149 | PubMed ID | 38070619 |
| Mgi Jnum | J:343704 | Mgi Id | MGI:7568619 |
| Doi | 10.1016/j.bbi.2023.12.002 | Citation | Dinevska M, et al. (2023) CREB: A multifaceted transcriptional regulator of neural and immune function in CNS tumors. Brain Behav Immun 116:140-149 |
| abstractText | Cancers of the central nervous system (CNS) are unique with respect to their tumor microenvironment. Such a status is due to immune-privilege and the cellular behaviors within a highly networked, neural-rich milieu. During tumor development in the CNS, neural, immune and cancer cells establish complex cell-to-cell communication networks which mimic physiological functions, including paracrine signaling and synapse-like formations. This crosstalk regulates diverse pathological functions contributing to tumor progression. In the CNS, regulation of physiological and pathological functions relies on various cell signaling and transcription programs. At the core of these events lies the cyclic adenosine monophosphate (cAMP) response element binding protein (CREB), a master transcriptional regulator in the CNS. CREB is a kinase inducible transcription factor which regulates many CNS functions, including neurogenesis, neuronal survival, neuronal activation and long-term memory. Here, we discuss how CREB-regulated mechanisms operating in diverse cell types, which control development and function of the CNS, are co-opted in CNS tumors. |
